Pieter Van Vlierberghe
Overview
Explore the profile of Pieter Van Vlierberghe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
5695
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Trimpont M, Schalk A, Hofkens K, Peeters E, TSas S, Vandemeulebroecke K, et al.
Cancer Lett
. 2024 Dec;
611:217404.
PMID: 39709177
L-asparaginase (L-ASNase) is crucial in treating pediatric acute lymphoblastic leukemia (ALL), but its use is hampered by side effects from the immunogenicity and L-glutaminase (L-GLNase) co-activity of FDA-approved bacterial L-ASNases,...
2.
Buratin A, Palhais B, Gaffo E, Roels J, Morscio J, Van Laere J, et al.
Haematologica
. 2024 Dec;
PMID: 39633556
Not available.
3.
Demoen L, Matthijssens F, Reunes L, Palhais B, Lintermans B, TSas S, et al.
Sci Adv
. 2024 Nov;
10(44):eado6765.
PMID: 39485844
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy. Current intensified therapeutic protocols coincide with severe side effects, and no salvage therapy is available for primary therapy-resistant or...
4.
Rahman S, Bloye G, Farah N, Demeulemeester J, Costa J, OConnor D, et al.
Blood
. 2024 Sep;
144(22):2319-2326.
PMID: 39316719
Oncogenes can be activated in cis through multiple mechanisms including enhancer hijacking events and noncoding mutations that create enhancers or promoters de novo. These paradigms have helped parse somatic variation...
5.
Tosello V, Di Martino L, Papathanassiu A, Santa S, Pizzi M, Mussolin L, et al.
Haematologica
. 2024 Sep;
110(2):350-367.
PMID: 39234857
High levels of branched-chain amino acid (BCAA) transaminase 1 (BCAT1) have been associated with tumor aggressiveness and drug resistance in several cancer types. Nevertheless, the mechanistic role of BCAT1 in...
6.
De Coninck S, Roels J, Lintermans B, TSas S, Taghon T, Curtis D, et al.
Blood Adv
. 2024 Mar;
8(11):2646-2649.
PMID: 38536906
No abstract available.
7.
Almeida A, TSas S, Pagliaro L, Fijalkowski I, Sleeckx W, Van Steenberge H, et al.
Hemasphere
. 2024 Mar;
8(3):e51.
PMID: 38463444
T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that accounts for 10%-15% of pediatric and 25% of adult ALL cases. Although the prognosis of T-ALL has improved over...
8.
Li Q, Guo H, Xu J, Li X, Wang D, Guo Y, et al.
iScience
. 2024 Jan;
27(1):108571.
PMID: 38161423
DHX15 has been implicated in RNA splicing and ribosome biogenesis, primarily functioning as an RNA helicase. To systematically assess the cellular role of DHX15, we conducted proteomic analysis to investigate...
9.
De Coninck S, De Smedt R, Lintermans B, Reunes L, Kosasih H, Reekmans A, et al.
Haematologica
. 2023 Nov;
109(5):1373-1384.
PMID: 37941480
T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) are rare aggressive hematologic malignancies. Current treatment consists of intensive chemotherapy leading to 80% overall survival but is associated with...
10.
Tulkens D, Boelens M, Naert T, Carron M, Demuynck S, Dewaele S, et al.
Leukemia
. 2023 Oct;
37(12):2404-2413.
PMID: 37794102
CRISPR-mediated simultaneous targeting of candidate tumor suppressor genes in Xenopus tropicalis allows fast functional assessment of co-driver genes for various solid tumors. Genotyping of tumors that emerge in the mosaic...